In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa: Results From a Multicenter Study in China, 2017

Antimicrobial Agents and Chemotherapy- United States

doi 10.1128/aac.02431-18

Full Text

Abstract

Available in

Date

January 7, 2019

Authors

Publisher

American Society for Microbiology

Related search

Evaluation of theIn VitroActivity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Meropenem-Resistant Pseudomonas Aeruginosa Isolates

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2016

English

Comparative Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Enterobacteriaceae Isolates Producing Extended-Spectrum Β-Lactamases From United States Hospitals

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2019

English

In Vitro Activity of Ceftazidime-Avibactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa Collected in Latin American Countries: Results From the INFORM Global Surveillance Program, 2012-2015

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2019

English

In Vitro Activity of Ceftazidime–avibactam, Ceftolozane–tazobactam, and Other Comparable Agents Against Clinically Important Gram-Negative Bacilli: Results From the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

Infection and Drug Resistance

Infectious Diseases

Pharmacology

2018

English

Antimicrobial Activity of Ceftazidime-Avibactam Tested Against Multidrug-Resistant Enterobacteriaceae and Pseudomonas Aeruginosa Isolates From United States Medical Centers (2013--2016)

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2017

English

Comparative in Vitro and in Vivo Efficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam Against Pseudomonas Aeruginosa

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2012

English

Comparison of Four Antimicrobial Susceptibility Testing Methods to Determine the in Vitro Activities of Piperacillin and Piperacillin-Tazobactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa

Journal of Clinical Microbiology

Microbiology

2003

English

Multicenter Study of Outcomes With Ceftazidime-Avibactam in Patients With Carbapenem-Resistant Enterobacteriaceae Infections

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2017

English

In Vitro Susceptibility of Ceftolozane-Tazobactam Against Burkholderia Pseudomallei

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2018

English

Amanote Research

In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa: Results From a Multicenter Study in China, 2017

Antimicrobial Agents and Chemotherapy- United States

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Evaluation of theIn VitroActivity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Meropenem-Resistant Pseudomonas Aeruginosa Isolates

Comparative Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Enterobacteriaceae Isolates Producing Extended-Spectrum Β-Lactamases From United States Hospitals

In Vitro Activity of Ceftazidime-Avibactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa Collected in Latin American Countries: Results From the INFORM Global Surveillance Program, 2012-2015

In Vitro Activity of Ceftazidime–avibactam, Ceftolozane–tazobactam, and Other Comparable Agents Against Clinically Important Gram-Negative Bacilli: Results From the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

Antimicrobial Activity of Ceftazidime-Avibactam Tested Against Multidrug-Resistant Enterobacteriaceae and Pseudomonas Aeruginosa Isolates From United States Medical Centers (2013--2016)

Comparative in Vitro and in Vivo Efficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam Against Pseudomonas Aeruginosa

Comparison of Four Antimicrobial Susceptibility Testing Methods to Determine the in Vitro Activities of Piperacillin and Piperacillin-Tazobactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa

Multicenter Study of Outcomes With Ceftazidime-Avibactam in Patients With Carbapenem-Resistant Enterobacteriaceae Infections

In Vitro Susceptibility of Ceftolozane-Tazobactam Against Burkholderia Pseudomallei

Amanote Research

In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa: Results From a Multicenter Study in China, 2017

Antimicrobial Agents and Chemotherapy- United States

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Evaluation of theIn VitroActivity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Meropenem-Resistant Pseudomonas Aeruginosa Isolates

Comparative Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Enterobacteriaceae Isolates Producing Extended-Spectrum Β-Lactamases From United States Hospitals

In Vitro Activity of Ceftazidime-Avibactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa Collected in Latin American Countries: Results From the INFORM Global Surveillance Program, 2012-2015

In Vitro Activity of Ceftazidime&ndash;avibactam, Ceftolozane&ndash;tazobactam, and Other Comparable Agents Against Clinically Important Gram-Negative Bacilli: Results From the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

Antimicrobial Activity of Ceftazidime-Avibactam Tested Against Multidrug-Resistant Enterobacteriaceae and Pseudomonas Aeruginosa Isolates From United States Medical Centers (2013--2016)

Comparative in Vitro and in Vivo Efficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam Against Pseudomonas Aeruginosa

Comparison of Four Antimicrobial Susceptibility Testing Methods to Determine the in Vitro Activities of Piperacillin and Piperacillin-Tazobactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa

Multicenter Study of Outcomes With Ceftazidime-Avibactam in Patients With Carbapenem-Resistant Enterobacteriaceae Infections

In Vitro Susceptibility of Ceftolozane-Tazobactam Against Burkholderia Pseudomallei

In Vitro Activity of Ceftazidime–avibactam, Ceftolozane–tazobactam, and Other Comparable Agents Against Clinically Important Gram-Negative Bacilli: Results From the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)